echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Buchang Pharmaceutical's two injections will be withdrawn from the Heilongjiang Provincial Medical Insurance List at the end of the year

    Buchang Pharmaceutical's two injections will be withdrawn from the Heilongjiang Provincial Medical Insurance List at the end of the year

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the evening of August 16, Buchang Pharmaceutical issued an announcement stating that the drug compound brain peptide ganglioside injection of the holding subsidiary Jilin Tiancheng Pharmaceutical and the drug Guhong injection of the wholly-owned subsidiary Tonghua Guhong Pharmaceutical will be held in December 2021.


    The announcement shows that the compound brain peptide ganglioside injection will have a revenue of 119 million yuan in Heilongjiang in 2020, and the Guhong injection will have a revenue of 126 million yuan in Heilongjiang in 2020, accounting for 0.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.